19 June 2013
Keywords: amylin, plans, restructuring, lead, 80m, reduction, cash
Article | 17 November 2008
Having posted disappointing third-quarter results, and seen its share price decline to a six-year low on worries about a delay ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 November 2008
24 November 2008
10 November 2008
© 2013 thepharmaletter.com